Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Gut-on-chip Utilization for Therapeutic design: Microbiome-epithelium interactions Model And Predictions

Project description

A digital twin of the gut

The gut lining plays a key role in health and susceptibility to disease, serving as a dynamic barrier where bacteria, mucus and mechanical forces interact. Understanding these interactions requires experimental models that faithfully replicate human gut physiology and computational tools capable of predicting therapeutic outcomes. With the support of the Marie Skłodowska-Curie Actions programme, the GUT-MicroMaP project aims to develop the first rigorously calibrated mathematical model of microbiome-epithelium interactions. This digital twin will capture microbial behaviour, mucus dynamics and metabolite gradients, serving as a predictive platform for designing microbiome-directed therapies including prebiotics, probiotics and phage treatments. The framework will account for inter-personal variation, ensuring broad relevance for personalised gut health interventions.

Objective

The gut epithelium is a dynamic interface where microbial metabolism, mucus structure, and mechanical cues jointly determine barrier function and disease susceptibility. Conventional approaches—such as fecal omics, animal models, and static Transwells—either lack human relevance or the spatiotemporal control required for predictive modeling and therapeutic design. Gut-on-chip devices have recently emerged as powerful tools to bridge this gap, reproducing key features of the human intestine, including oxygen gradients, peristaltic-like flow, mucus layers, and co-culture with anaerobic microbial consortia. These systems enable causal experiments under controlled regimes, yet their use has remained largely descriptive, and no predictive computational framework exists to generalize experimental results or guide rational intervention strategies.
GUT-MicroMaP addresses this gap by developing and validating the first rigorously calibrated, spatially explicit mathematical model of microbiome–epithelium interactions in gut-on-chip systems. The project will integrate high-resolution spatial multi-omics data from the 3D’omics consortium with hybrid PDE–ABM–CFD modeling to create a digital twin of the gut environment. This model will capture microbial motility, adhesion, and biofilm dynamics under metabolites and mucus conditions, and will be iteratively refined through Bayesian calibration and sensitivity analysis. Once validated, it will serve as an in-silico platform to design microbiome-directed therapeutic strategies—including prebiotics, probiotics, and phage therapies—optimizing barrier integrity while suppressing pathogens. Therapeutic insights will integrate sex/gender variability in gut physiology and immunity, ensuring broader relevance and equity. By merging spatial omics with advanced modeling, GUT-MicroMaP will deliver a transformative predictive framework for gut health, opening new avenues for rational therapeutic design in microbiome research.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

KATHOLIEKE UNIVERSITEIT LEUVEN
Net EU contribution
€ 216 240,00
Address
OUDE MARKT 13
3000 Leuven
Belgium
Region
Vlaams Gewest Prov. Vlaams-Brabant Arr. Leuven
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (2)